Shin Ariga

Sapporo, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

mTOR-Responsive PIK3CA p.E542K-Harboring Sweat Gland Carcinoma With Neuroendocrine Differentiation.

mTOR-Responsive PIK3CA p.E542K-Harboring Sweat Gland Carcinoma With Neuroendocrine Differentiation.

Journal: International journal of dermatology
Published: April 20, 2026

Characterization of the mutational landscapes in Japanese patients with early-onset colorectal cancer from comprehensive genomic profiling data.

Characterization of the mutational landscapes in Japanese patients with early-onset colorectal cancer from comprehensive genomic profiling data.

Journal: International journal of clinical oncology
Published: July 17, 2025

Clinical utility of comprehensive genomic profiling test for colorectal cancer: a single institution prospective observational study.

Clinical utility of comprehensive genomic profiling test for colorectal cancer: a single institution prospective observational study.

Journal: Journal of cancer research and clinical oncology
Published: July 13, 2025

Cryptococcal Lung Infection Simulating Metastasis in a Myxoid Liposarcoma Patient: A Case Report.

Cryptococcal Lung Infection Simulating Metastasis in a Myxoid Liposarcoma Patient: A Case Report.

Journal: Case reports in infectious diseases
Published: February 22, 2025

Prostatic Stromal Sarcoma With SMARCA4 Mutation: A Case Report.

Prostatic Stromal Sarcoma With SMARCA4 Mutation: A Case Report.

Journal: Pathology international
Published: January 30, 2025

Actionable Gene Alterations Identified in Patients With Malignant Melanoma by Targeted Sequencing in Japan.

Actionable Gene Alterations Identified in Patients With Malignant Melanoma by Targeted Sequencing in Japan.

Journal: JCO precision oncology
Published: January 17, 2025

Early prediction of treatment outcome for lenvatinib using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma refractory to radioiodine treatment: a prospective, multicentre, non-randomised study.

Early prediction of treatment outcome for lenvatinib using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma refractory to radioiodine treatment: a prospective, multicentre, non-randomised study.

Journal: EJNMMI research
Published: May 15, 2023

History and Future of HER2-Targeted Therapy for Advanced Gastric Cancer.

History and Future of HER2-Targeted Therapy for Advanced Gastric Cancer.

Journal: Journal of clinical medicine
Published: March 20, 2023

Crystalline silica-exposed human lung epithelial cells presented enhanced anchorage-independent growth with upregulated expression of BRD4 and EZH2 in autocrine and paracrine manners.

Crystalline silica-exposed human lung epithelial cells presented enhanced anchorage-independent growth with upregulated expression of BRD4 and EZH2 in autocrine and paracrine manners.

Journal: PloS one
Published: December 09, 2022

EGFR inhibition in EGFR-mutant lung cancer cells perturbs innate immune signaling pathways in the tumor microenvironment.

EGFR inhibition in EGFR-mutant lung cancer cells perturbs innate immune signaling pathways in the tumor microenvironment.

Journal: Cancer science
Published: June 24, 2022

Phase II trial of combination treatment with S-1/cetuximab in patients with platinum-ineligible recurrent and/or metastatic squamous cell carcinoma of the head and neck.

Phase II trial of combination treatment with S-1/cetuximab in patients with platinum-ineligible recurrent and/or metastatic squamous cell carcinoma of the head and neck.

Journal: International journal of clinical oncology
Published: April 29, 2020

Early prediction of lenvatinib treatment efficacy by using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma that is refractory to radioiodine treatment: a protocol for a non-randomized single-arm multicenter observational study.

Early prediction of lenvatinib treatment efficacy by using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma that is refractory to radioiodine treatment: a protocol for a non-randomized single-arm multicenter observational study.

Journal: BMJ open
Published: September 01, 2018
Showing 1-12 of 13

Last Updated: 09/26/2026